Search results - ORA - Oxford University Research Archive

1

Thesis

Regulatory network analyses highlight transcription factor cooperation in haematopoiesis and leukaemogenesis

Harman, J
2023

2

Journal article

Acid-resistant BODIPY amino acids for peptide-based fluorescence imaging of GPR54 receptors in pancreatic islets

Mendive-Tapia, L, Miret-Casals, L, Barth, ND, et al.
2023-03-14

3

Journal article

Single-cell methods in myeloproliferative neoplasms: old questions, new technologies

O'Sullivan, JM, Mead, AJ, Psaila, B
2023-01-26

4

Thesis

Single-cell analysis of alternative splicing in normal and malignant stem/progenitor cells

Wen, S
2022

5

Thesis

Dissecting the impact of chimeric antigen receptor expression levels on T cell behaviour and response

Ramos, AS
2022

6

Journal article

Digital blood glucose monitoring could provide new objective assessments of blood glucose control in women with gestational diabetes

Hirst, JE, Loerup, L, Mackillop, L, et al.
2016-10-17

7

Thesis

CRISPR/Cas9-mediated engineering of subtype-specific cell lines for iPSC-derived cardiomyocyte phenotyping

Sontayananon, N
2022

8

Thesis

Engineering a modular virus-like particle platform for enhanced vaccine assembly

Wu, H-J
2022

9

Thesis

The mechanistic modelling and simulation of vaccine-adjuvant induced immune responses

Buckley, PR
2021

10

Journal article

Basophils promote barrier dysfunction and resolution in the atopic skin

Pellefigues, C, Naidoo, K, Mehta, P, et al.
2021-03-01

11

Journal article

Eosinophils determine dermal thickening and water loss in an MC903 model of atopic dermatitis

Naidoo, K, Jagot, F, van den Elsen, L, et al.
2018-07-02

12

Journal article

pH and proton sensor GPR65 determine susceptibility to atopic dermatitis

Xie, L, McKenzie, CI, Qu, X, et al.
2021-07-01

13

Conference item

Identification of thirty novel loci for cardiovascular magnetic resonance derived aortic distensibility in the UK Biobank

Fung, K, Biasiolli, L, Hann, E, et al.
2021-11-01

14

Conference item

A high-throughput cell culture model of idiopathic pulmonary fibrosis (IPF) for gene therapy applications

Cerezuela, MP, Munis, AM, Du, Y, et al.
2022-05-02

15

Conference item

F/HN pseudotyped lentiviral vector uses alpha 2,3 sialylated N-acetyllactosamine to efficiently transduce human airway cells

Munday, RJ, Coradin, T, Nimmo, R, et al.
2022-05-02

16

Thesis

Unconventional functions of MR1 restricted T-cells

Delowar Akther, H
2023

17

Journal article

Cell networks in endocrine/neuroendocrine gland function

Guérineau, NC, Campos, P, Le Tissier, PR, et al.
2022-03-29

18

Journal article

PEPITEM modulates leukocyte trafficking to reduce obesity-induced inflammation

Pezhman, L, Hopkin, S, Begum, J, et al.
2023

19

Thesis

Imaging biomarkers for cardiovascular risk prediction with CT techniques

Kluner, LV
2022

20

Conference item

Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)

Wamil, M, Coleman, RL, Adler, A, et al.
2020-06-01

21

Journal article

Ex vivo expansion and genetic manipulation of mouse hematopoietic stem cells in polyvinyl alcohol-based cultures

Khoo, HM, Meaker, GA, Wilkinson, AC
2022

22

Journal article

Acute response in the noninfarcted myocardium predicts long-term major adverse cardiac events after STEMI

Shanmuganathan, M, Masi, A, Burrage, MK, et al.
2022-12-14

23

Journal article

CNL and aCML should be considered as single entity based on molecular profiles and outcomes

Carreño-Tarragona, G, Alvarez-Larran, A, Harrison, CN, et al.
2022-11-14

24

Journal article

ESC CVD Prevention Guidelines 2021: improvements, controversies, and opportunities

Antoniades, C, West, HW
2022-01-17

25

Thesis

The impact of ageing on trauma-related bleeding and coagulopathy

Henna, W
2020

26

Journal article

Virus detection and identification in minutes using single-particle imaging and deep learning

Shiaelis, N, Tometzki, A, Peto, L, et al.
2022

27

Conference item

Towards 2D phase-contrast of tricuspid valve flow

Lamy, J, Seemann, F, Gonzales, RA, et al.
2022-04-22

28

Conference item

Isovolumic relaxation time and e' metrics evaluated by deep-learning analysis of long-axis cine: correlations to atrial pressure and fibrosis

Peters, D, Lamy, J, Seemann, F, et al.
2021-04-30

29

Journal article

Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic

McGregor, CG, Adams, A, Sadler, R, et al.
2021-02-12

30

Conference item

A phase 3, randomized, open-label study evaluating the safety and efficacy of magrolimab in combination with azacitidine in previously untreated patients with TP53-mutant acute myeloid leukemia

Daver, N, Vyas, P, Chao, MP, et al.
2022-10-13

31

Conference item

Magrolimab in combination with azacitidine for patients with untreated higher-risk myelodysplastic syndromes: 5F9005 phase 1b study results

Sallman, DA, Al Malki, MM, Asch, AS, et al.
2022-10-13

32

Conference item

MDS-445 Magrolimab in combination with azacitidine for patients with untreated higher-risk myelodysplastic syndromes (HR MDS): 5F9005 phase 1b study results

Sallman, D, Malki, MA, Asch, A, et al.
2022-09-21

33

Conference item

AML-348 A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated hematologic malignancies

Lachowiez, C, Borthakur, G, Loghavi, S, et al.
2022-09-21

34

Conference item

A phase 3, randomized trial of magrolimab in combination with venetoclax and azacitidine in previously untreated patients with acute myeloid leukemia ineligible for intensive chemotherapy (ENHANCE-3)

Daver, N, Liu, K, Werneke, S, et al.
2022-10-13

35

Conference item

AML-432 Overall survival (OS) by IDH2 mutant allele (R140 or R172) in patients with late-stage, mutant-IDH2 relapsed/refractory acute myeloid leukemia (AML) treated with enasidenib or conventional care regimens (CCR) in the randomized, open-label, Phase 3 IDHENTIFY Trial

DiNardo, CD, de Botton, S, Risueño, A, et al.
2022-09-21

36

Conference item

AML-464 Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in frontline patients with TP53-mutated acute myeloid leukemia (AML): Phase 1b results

Daver, N, Vyas, P, Kambhampati, S, et al.
2022-09-21

37

Conference item

AML-399 A phase 2, open-label, multiarm, multicenter study to evaluate magrolimab combined with antileukemia therapies for first-line, relapsed/refractory, or maintenance treatment of acute myeloid leukemia (AML)

Vyas, P, Daver, N, Chao, M, et al.
2022-09-21

38

Journal article

AML-262 Pivekimab Sunirine (PVEK, IMGN632) triplet with azacitidine and venetoclax shows broad activity in adverse genetic subsets of relapsed/refractory acute myeloid leukemia and reduced infusion-related reactions

Daver, N, Montesinos, P, Aribi, A, et al.
2022-09-21

39

Conference item

MDS-482 Impact of magrolimab in combination with azacitidine on red blood cells (RBCs) in patients with higher-risk myelodysplastic syndromes (HR MDS)

Chen, J, Johnson, L, McKenna, K, et al.
2022-09-21

40

Journal article

Enzyme self-label-bound ATTO700 in single molecule and super-resolution microscopy

Trumpp, M, Oliveras-Martinez, A, Gonschior, H, et al.
2022

41

Journal article

Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex

Patone, M, Mei, XW, Handunnetthi, L, et al.
2022-08-22

42

Conference item

Measuring pcr/atp as a marker of myocardial energetics across the spectrum of metabolic cardiac disease

Henry, JA, Levelt, E, Rayner, J, et al.
2022-06-06

43

Conference item

Mutation agnostic diagnosis of clonal hematopoiesis of indeterminate potential (CHIP) using fluctuating methylation clocks

Schenck, RO, Jakobsen, NA, Turati, V, et al.
2022-05-15

44

Conference item

Repressed chromatin drives leukaemogenesis in mutant IDH2 acute myeloid leukaemia via inhibition of granulocyte differentiation and cell cycle progression

Silveira, DRA, Chatzikyriakou, P, Yavorska, O, et al.
2021-11-23

45

Conference item

Outcomes for patients with late-stage mutant-IDH2 (m IDH2) relapsed/refractory acute myeloid leukemia (R/R AML) treated with enasidenib vs other lower-intensity therapies in the randomized, phase 3 IDHentify Trial

DiNardo, CD, Montesinos, P, Schuh, AC, et al.
2021-11-23

46

Conference item

Loss of COP9 signalosome gene-containing 2q region is associated with lenalidomide and pomalidomide resistance in myeloma patients

Gooding, S, Ansari-Pour, N, Kazeroun, MH, et al.
2021-11-23

47

Conference item

Health-related quality of life (HRQoL) during treatment with enasidenib (ENA) plus azacitidine (AZA) in patients with newly diagnosed mutant IDH2 (m IDH2) acute myeloid leukemia (AML) not eligible for intensive chemotherapy (IC)

DiNardo, CD, Dohner, H, Zeidan, AM, et al.
2021-11-23

48

Conference item

A phase 3, randomized, open-label study evaluating the safety and efficacy of magrolimab in combination with azacitidine in previously untreated patients with TP53-mutant acute myeloid leukemia

Daver, N, Vyas, P, Chao, M, et al.
2021-11-23

49

Journal article

International Consensus Classification of myeloid neoplasms and acute leukemia: Integrating morphological, clinical, and genomic data.

Arber, DA, Orazi, A, Hasserjian, RP, et al.
2022-06-29

50

Conference item

A phase 2, open-label, multiarm, multicenter study to evaluate magrolimab combined with antileukemia therapies for first-line, relapsed/refractory, or maintenance treatment of acute myeloid leukemia

Vyas, P, Daver, N, Chao, M, et al.
2021-11-23